290 related articles for article (PubMed ID: 29017520)
21. Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator.
Lim W; Park Y; Cho J; Park C; Park J; Park YK; Park H; Lee Y
Breast Cancer Res; 2011 Mar; 13(2):R32. PubMed ID: 21435239
[TBL] [Abstract][Full Text] [Related]
22. Small molecule inhibition of RISC loading.
Tan GS; Chiu CH; Garchow BG; Metzler D; Diamond SL; Kiriakidou M
ACS Chem Biol; 2012 Feb; 7(2):403-10. PubMed ID: 22026461
[TBL] [Abstract][Full Text] [Related]
23. Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer.
Alexandrova E; Lamberti J; Saggese P; Pecoraro G; Memoli D; Cappa VM; Ravo M; Iorio R; Tarallo R; Rizzo F; Collina F; Cantile M; Bonito MD; Botti G; Nassa G; Weisz A; Giurato G
Cells; 2020 Apr; 9(4):. PubMed ID: 32260128
[TBL] [Abstract][Full Text] [Related]
24. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2.
Shen J; Xia W; Khotskaya YB; Huo L; Nakanishi K; Lim SO; Du Y; Wang Y; Chang WC; Chen CH; Hsu JL; Wu Y; Lam YC; James BP; Liu X; Liu CG; Patel DJ; Hung MC
Nature; 2013 May; 497(7449):383-7. PubMed ID: 23636329
[TBL] [Abstract][Full Text] [Related]
25. DICER-ARGONAUTE2 complex in continuous fluorogenic assays of RNA interference enzymes.
Bernard MA; Wang L; Tachado SD
PLoS One; 2015; 10(3):e0120614. PubMed ID: 25793518
[TBL] [Abstract][Full Text] [Related]
26. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
27. The Ago2-miRNA-co-IP Assay to Study TGF- β1 Mediated Recruitment of miRNA to the RISC in CFBE Cells.
Mitash N; Donovan JE; Swiatecka-Urban A
J Vis Exp; 2020 Jul; (161):. PubMed ID: 32894261
[TBL] [Abstract][Full Text] [Related]
28. PES1 promotes breast cancer by differentially regulating ERα and ERβ.
Cheng L; Li J; Han Y; Lin J; Niu C; Zhou Z; Yuan B; Huang K; Li J; Jiang K; Zhang H; Ding L; Xu X; Ye Q
J Clin Invest; 2012 Aug; 122(8):2857-70. PubMed ID: 22820289
[TBL] [Abstract][Full Text] [Related]
29. Clarifying mammalian RISC assembly in vitro.
Tan GS; Garchow BG; Liu X; Metzler D; Kiriakidou M
BMC Mol Biol; 2011 Apr; 12():19. PubMed ID: 21529364
[TBL] [Abstract][Full Text] [Related]
30. Expanded RNA-binding activities of mammalian Argonaute 2.
Tan GS; Garchow BG; Liu X; Yeung J; Morris JP; Cuellar TL; McManus MT; Kiriakidou M
Nucleic Acids Res; 2009 Dec; 37(22):7533-45. PubMed ID: 19808937
[TBL] [Abstract][Full Text] [Related]
31. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy reveal the cytoplasmic origination of loaded nuclear RISC in vivo in human cells.
Ohrt T; Mütze J; Staroske W; Weinmann L; Höck J; Crell K; Meister G; Schwille P
Nucleic Acids Res; 2008 Nov; 36(20):6439-49. PubMed ID: 18842624
[TBL] [Abstract][Full Text] [Related]
33. RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer.
Hashim A; Rizzo F; Marchese G; Ravo M; Tarallo R; Nassa G; Giurato G; Santamaria G; Cordella A; Cantarella C; Weisz A
Oncotarget; 2014 Oct; 5(20):9901-10. PubMed ID: 25313140
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Ago2 Loading by Cyclophilin 40 Endows a Unique Repertoire of Functional miRNAs during Sperm Maturation in Drosophila.
Iki T; Takami M; Kai T
Cell Rep; 2020 Nov; 33(6):108380. PubMed ID: 33176138
[TBL] [Abstract][Full Text] [Related]
35. Argonaute-1 binds transcriptional enhancers and controls constitutive and alternative splicing in human cells.
Alló M; Agirre E; Bessonov S; Bertucci P; Gómez Acuña L; Buggiano V; Bellora N; Singh B; Petrillo E; Blaustein M; Miñana B; Dujardin G; Pozzi B; Pelisch F; Bechara E; Agafonov DE; Srebrow A; Lührmann R; Valcárcel J; Eyras E; Kornblihtt AR
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15622-9. PubMed ID: 25313066
[TBL] [Abstract][Full Text] [Related]
36. Identifying RISC Components Using Ago2 Immunoprecipitation and Mass Spectrometry.
Yi T
Methods Mol Biol; 2018; 1720():149-159. PubMed ID: 29236257
[TBL] [Abstract][Full Text] [Related]
37. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
38. ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.
Carissimi C; Laudadio I; Cipolletta E; Gioiosa S; Mihailovich M; Bonaldi T; Macino G; Fulci V
Nucleic Acids Res; 2015 Feb; 43(3):1498-512. PubMed ID: 25605800
[TBL] [Abstract][Full Text] [Related]
39. Argonaute 2 Binds Directly to tRNA Genes and Promotes Gene Repression in cis.
Woolnough JL; Atwood BL; Giles KE
Mol Cell Biol; 2015 Jul; 35(13):2278-94. PubMed ID: 25918241
[TBL] [Abstract][Full Text] [Related]
40. Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer.
Casey MC; Prakash A; Holian E; McGuire A; Kalinina O; Shalaby A; Curran C; Webber M; Callagy G; Bourke E; Kerin MJ; Brown JA
BMC Cancer; 2019 Jul; 19(1):712. PubMed ID: 31324173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
